Corcept Therapeutics faces securities lawsuit after FDA rejection

March 17, 2026 11:34 PM

Corcept Therapeutics Incorporated (NASDAQ: CORT) is subject to a securities class action lawsuit following the FDA's rejection of its drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found